4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-17-016105
Options or other derivatives
- Director acquired 21,479 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bronstein Ben Director | 2017-06-08 | Grant or award · Stock Option (Right to Buy) | +17,776 | 17,776 | D | ||
| Bronstein Ben Director | 2017-06-08 | Grant or award · Stock Option (Right to Buy) | +2,222 | 2,222 | D | ||
| Bronstein Ben Director | 2017-06-08 | Grant or award · Stock Option (Right to Buy) | +1,481 | 1,481 | D | ||
Loading xslF345X03/doc4.xml…